IL-18-induced CD83+CCR7+ NK helper cells

被引:237
作者
Mailliard, RB
Alber, SM
Shen, HM
Watkins, SC
Kirkwood, JM
Herberman, RB
Kalinski, P
机构
[1] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
[5] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA
[6] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15213 USA
[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
关键词
D O I
10.1084/hem.20050128
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to their cytotoxic activities, natural killer (NK) cells can have immunoregulatory functions. We describe a distinct "helper" differentiation pathway of human CD56(+) CD3(-) NK cells into CD56(+)/CD83(+)/CCR7(+)/CD25(+) cells that display high migratory responsiveness to lymph node (LN)-associated chemokines, high ability to produce interferon-gamma upon exposure to dendritic cell (DC)- or T helper (Th) cell-related signals, and pronounced abilities to promote interleukin (IL)-12p70 production in DCs and the development of Th1 responses. This helper pathway of NK cell differentiation, which is not associated with any enhancement of cytolytic activity, is induced by IL-18, but not other NK cell - activating ;factors. It is blocked by prostaglandin (PG)E-2, a factor that induces a similar CD83(+)/CCR7(+)/ CD25(+) LN-homing phenotype in maturing DCs. The current data demonstrate independent regulation of the "helper" versus "effector" pathways of NK cell differentiation and novel mechanisms of immunoregulation by IL-18 and PGE(2).
引用
收藏
页码:941 / 953
页数:13
相关论文
共 60 条
[1]   The role of IL-18 in innate immunity [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :59-63
[2]  
BETZ M, 1991, J IMMUNOL, V146, P108
[3]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[4]   CD56(bright) natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand [J].
Carson, WE ;
Fehniger, TA ;
Caligiuri, MA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :354-360
[5]   Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells [J].
Castriconi, R ;
Cantoni, C ;
Della Chiesa, M ;
Vitale, M ;
Marcenaro, E ;
Conte, R ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4120-4125
[6]   Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm [J].
Clerici, M ;
Shearer, GM ;
Clerici, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (04) :261-263
[7]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[8]  
Cooper GJS, 2001, AUST J DAIRY TECHNOL, V56, P97
[9]   NK cell and DC interactions [J].
Cooper, MA ;
Fehniger, TA ;
Fuchs, A ;
Colonna, M ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :47-52
[10]  
de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771